Terms: = Uterine cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
82 results:
1. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.
Heremans R; Wynants L; Valentin L; Leone FPG; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Van den Bosch T;
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):556-563. PubMed ID: 37927006
[TBL] [Abstract] [Full Text] [Related]
2. Determinants of precancerous cervical lesion among HIV infected women on ART in Woldia comprehensive specialized hospital NorthEast Ethiopia.
Dessie TM; Kassaw AT; Alen GD
BMC Womens Health; 2023 Aug; 23(1):458. PubMed ID: 37644484
[TBL] [Abstract] [Full Text] [Related]
3. Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer.
Guo L; Wang W; Xie X; Wang S; Zhang Y
Biomed Pharmacother; 2023 May; 161():114518. PubMed ID: 36906972
[TBL] [Abstract] [Full Text] [Related]
4. Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy.
Aichi M; Hasegawa S; Kurita Y; Shinoda S; Kato S; Mizushima T; Yokota NR; Miyagi E
Nutrition; 2023 May; 109():111966. PubMed ID: 36731243
[TBL] [Abstract] [Full Text] [Related]
5. Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study.
Barr CE; Sergeant JC; Agnew HJ; Bolton J; McVey RJ; Crosbie EJ
BJOG; 2023 Jul; 130(8):941-948. PubMed ID: 36715558
[TBL] [Abstract] [Full Text] [Related]
6. A population-based risk scoring system to individualize adjuvant treatment for stage IIIC endometrial cancer patients after surgery.
Yang XL; Zhang YE; Kou LN; Yang FL; Wu DJ
Eur J Surg Oncol; 2023 Feb; 49(2):475-480. PubMed ID: 36114049
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of FAM19A4/miR124-2 methylation performance in the management of CIN3 diagnosed pregnant women.
Hampl M; Hesselink AT; Meijer CJLM; Denecke A; Einhorn I; Reinecke-Luethge A; Geppert CI; Jentschke M; ; Petry KU; Hillemanns P
Int J Cancer; 2022 Nov; 151(9):1578-1585. PubMed ID: 35666529
[TBL] [Abstract] [Full Text] [Related]
8. Racial and Ethnic Differences in Hysterectomy-Corrected uterine Corpus cancer Mortality by Stage and Histologic Subtype.
Clarke MA; Devesa SS; Hammer A; Wentzensen N
JAMA Oncol; 2022 Jun; 8(6):895-903. PubMed ID: 35511145
[TBL] [Abstract] [Full Text] [Related]
9. Ultrasound features of endometrial pathology in women without abnormal uterine bleeding: results from the International Endometrial Tumor Analysis study (IETA3).
Heremans R; Van Den Bosch T; Valentin L; Wynants L; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Leone FPG;
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):243-255. PubMed ID: 35385178
[TBL] [Abstract] [Full Text] [Related]
10. A Scoping Review of Cervical cancer Risk Factors, Prevention, Diagnosis, and treatment in U.S. Active Duty Military Women.
Braun LA; Kostas-Polston EA; Miedema J; Hoffecker L; Wilson C
Womens Health Issues; 2021 Aug; 31 Suppl 1():S53-S65. PubMed ID: 34454704
[TBL] [Abstract] [Full Text] [Related]
11. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
[TBL] [Abstract] [Full Text] [Related]
12. A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial cancer and Validation of Biomarkers of Cellular Response.
Duska LR; Filiaci VL; Walker JL; Holman LL; Hill EK; Moore RG; Ring KL; Pearl ML; Muller CY; Kushnir CL; Lankes HA; Samuelson MI; Carrick KS; Rajan A; Rodgers WH; Kohn EC; Piekarz R; Leslie KK
Clin Cancer Res; 2021 May; 27(10):2734-2741. PubMed ID: 33766814
[TBL] [Abstract] [Full Text] [Related]
13. The effect of local photodynamic therapy with 5-aminolevulinic acid for the treatment of cervical low-grade squamous intraepithelial lesions with high-risk HPV infection: A retrospective study.
Gu L; Cheng M; Hong Z; Di W; Qiu L
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102172. PubMed ID: 33401023
[TBL] [Abstract] [Full Text] [Related]
14. Ultrasound Microbubble-Mediated microRNA-505 Regulates Cervical cancer Cell Growth via akt2.
Xu L; Zhang Q; Li C; Hua F; Liu X
Anal Cell Pathol (Amst); 2020; 2020():3731953. PubMed ID: 33123457
[TBL] [Abstract] [Full Text] [Related]
15. Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas?
Benito V; Lubrano A; León L; Molano F; Pinar B
Int J Gynecol Cancer; 2020 Nov; 30(11):1726-1732. PubMed ID: 32948637
[TBL] [Abstract] [Full Text] [Related]
16. Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes.
Anton C; Kleine RT; Mayerhoff E; Diz MDPE; Freitas D; Carvalho HA; Carvalho JPM; Silva ASE; Genta MLND; Silva ALFE; Salim RC; Aranha A; Lopez RVM; Carvalho FM; Baracat EC; Carvalho JP
PLoS One; 2020; 15(3):e0229543. PubMed ID: 32134921
[TBL] [Abstract] [Full Text] [Related]
17. Impact of quality of care on racial disparities in survival for endometrial cancer.
Huang AB; Huang Y; Hur C; Tergas AI; Khoury-Collado F; Melamed A; St Clair CM; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2020 Sep; 223(3):396.e1-396.e13. PubMed ID: 32109459
[TBL] [Abstract] [Full Text] [Related]
18. Regular Low-Dose Oral Metronidazole Is Associated With Fewer Vesicovaginal and Rectovaginal Fistulae in Recurrent Cervical cancer: Results From a 10-Year Retrospective Cohort.
George R; Prasoona TS; Kandasamy R; Mani T; Murali S; Rekha R; Muliyil J
J Glob Oncol; 2019 Sep; 5():1-10. PubMed ID: 31479340
[TBL] [Abstract] [Full Text] [Related]
19. [Effects of metformin on the expression of estrogen synthetase and ER mRNA in uterine leiomyoma tissues].
Wang SY; Xue Q; Zhou YF; Yin L
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):249-254. PubMed ID: 31006191
[No Abstract] [Full Text] [Related]
20. Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial cancer at a High Risk of Progression: A Randomized Clinical Trial.
Nomura H; Aoki D; Michimae H; Mizuno M; Nakai H; Arai M; Sasagawa M; Ushijima K; Sugiyama T; Saito M; Tokunaga H; Matoda M; Nakanishi T; Watanabe Y; Takahashi F; Saito T; Yaegashi N;
JAMA Oncol; 2019 Jun; 5(6):833-840. PubMed ID: 30896757
[TBL] [Abstract] [Full Text] [Related]
[Next]
